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Clostridium difficile is a pathogenic bacterium
causing gastrointestinal diseases from mild diarrhea
to toxic megacolon. In common with other patho-
genic bacteria, C. difficile secretes proteins involved
in adhesion, colonization, and dissemination. The
recently identified Zmp1 is an extracellular metallo-
protease showing a unique specificity for Pro-Pro
peptide bonds. The endogenous substrates of
Zmp1 are two surface proteins implicated in adhe-
sion of C. difficile to surface proteins of human cells.
Thus, Zmp1 is believed to be involved in the regula-
tion of the adhesion-motility balance of C. difficile.
Here, we report crystal structures of Zmp1 from
C. difficile in its unbound and peptide-bound forms.
The structure analysis revealed a fold similar toBacil-
lus anthracis lethal factor. Crystal structures in the
open and closed conformation of the S-loop shed
light on the mode of binding of the substrate, and
reveal important residues for substrate recognition
and the strict specificity of Zmp1 for Pro-Pro peptide
bonds.
INTRODUCTION
Zinc-dependent endoproteases are involved in many essential
biological processes such as protein degradation, proenzyme
activation, and amino acid supply (Neurath and Walsh, 1976).
A majority of these enzymes belong to the MEROPS clan MA
(Rawlings et al., 2014) and exhibit the conserved sequence motif
HEXXH, where the two histidines ligate the catalytic zinc ion, and
the glutamic acid acts as catalytic base activating a zinc-bound
water molecule for nucleophilic attack on the scissile peptide
bond (Matthews, 1988). A subgroup of the MA clan is the M34
family of metalloendopeptidases (Rawlings et al., 2014). Among
its members are the lethal factor (LF) from Bacillus anthracis and
the recently discovered Zmp1 from Clostridium difficile (Cafardi
et al., 2013; Hensbergen et al., 2014).
In the past decade, C. difficile has become one of the major
causes of nosocomial antibiotic-associated diarrhea infections
(Bouza, 2012). It is transmitted through the spore form of this
Gram-positive anaerobic bacterium via the fecal-oral route1632 Structure 23, 1632–1642, September 1, 2015 ª2015 Elsevier Lt(Brazier, 1998).C. difficile-associated disease (CDAD) is a severe
and often fatal colon inflammation with symptoms ranging from
diarrhea (George et al., 1977) to pseudomembranous colitis
(George et al., 1978) and toxic megacolon (Bartlett, 2006). The
risk group for this disease are hospitalized patients older than
65 years after antimicrobial treatment, e.g. with clindamycin
(Bartlett et al., 1978; Thomas et al., 2003). Owing to its high
recurrence and high mortality rate, C. difficile infections have
become amajor problem in hospitals and nursing homes (Makris
and Gelone, 2007). The emergence of the ‘‘epidemic’’ or ‘‘hyper-
virulent’’ strains BI/NAP1/027 in North America and Europe has
caused a drastic increase in new infections and fatality rates in
the last 15 years (O’Connor et al., 2009).
Zmp1 is secreted by allC. difficile strains, including the virulent
and multidrug-resistant NAP1 ribotype 027 strain R20291 (Ca-
fardi et al., 2013). It is implicated in the regulation of C. difficile
motility (Figure 1) through cleavage of the putative C. difficile
adhesins CD2831 and CD3246 (Hensbergen et al., 2014), which
makes it an interesting target to study. It was shown for other
human pathogens that proteases involved in adhesion, coloniza-
tion, and dissemination are essential for infections and
recurrence, as for example reported for the regulation of
B. anthracis adhesion to human endothelial cells via the cleavage
of the major surface layer protein BslA by the secreted protease
InhA (Tonry et al., 2012). Similarly, Bordetella pertussis SphB1
protease maturates the major adhesin filamentous hemaggluti-
nin at the cell surface (Coutte et al., 2003b), and the knockout
of SphB1 strongly affects the ability of B. pertussis to colonize
the mouse respiratory tract in vivo (Coutte et al., 2003a). Taking
into account these observations, Zmp1 could be a potential drug
target for CDAD treatment of new, but also of recurrent,
C. difficile infections.
While no three-dimensional structural information is available
for Zmp1 or close orthologs, there is a weak similarity (less
than 20% sequence identity) to B. anthracis LF, which is
composed of four domains (Pannifer et al., 2001), namely
the N-terminal protective-antigen-binding domain (PA-binding
domain) I, domains II and III responsible for substrate binding,
and the metalloprotease domain IV, which is distantly related
to thermolysin (Matthews, 1988).
In LF the third zinc ligand is a glutamic acid C-terminal of the
two histidines, and a tyrosine residue that is assumed to stabilize
the tetrahedral intermediate of the hydrolysis reaction is spatially
located near the zinc ion (Pannifer et al., 2001; Tonello et al.,
2004). LF is part of the tripartite anthrax toxin of B. anthracis
(Smith et al., 1956; Beall et al., 1962). Its main substrates ared All rights reserved
Figure 1. Model of Proposed Role of Zmp1 and Sequence Conservation in Zmp1 Substrates
(A) Model of the possible role of Zmp1 in the regulation of motility inC. difficile infections. Secreted Zmp1, the endogenousC. difficile substrate adhesins CD2831
and CD3246, as well as the receptor molecules on the enterocyte surface are depicted.
(B) Prevalent amino acids around the scissile bond (positions P4–P40) in the endogenous C. difficile substrates CD2831 and CD3246 in WebLogo format (Crooks
et al., 2004).
(C) Sequences found in the human protein substrates IgA1/2, Hsp90b, and fibrinogen, as in (A).
(D) Amino acids at the P3 to P30 positions previously identified in a peptidic screen. The inverted triangles indicate the protease cleavage sites.mitogen-activated protein kinase kinases (MAPKKs) (Duesbery
et al., 1998; Pellizzari et al., 1999; Vitale et al., 2000). The
conserved amino acids around the scissile bond in MAPKKs
are (P1)[Pro/Arg/Lys/Gln/Gly];[Ile/Ala/Leu/Phe](P10), where ;
symbolizes the scissile bond and P1 and P10 denote the neigh-
boring residues (Schechter and Berger, 1967). In a peptide
screen the recognition motif was determined as (P1)Pro;[Tyr/
Leu/Ile/Met/Phe/Val](P10) (Turk et al., 2004).
C. difficile Zmp1, on the other hand, shows a very unique
specificity for Pro-Pro peptide bonds that is different from LF
(Hensbergen et al., 2014). Its preferred recognition sequence
in proteinaceous substrates is (P4)Val-[Val/Leu/Ile]-Asn-Pro;
Pro-Val-Pro-Pro(P40) with a stringent specificity for Asn in the
P2, and Pro in the P1, P10, and P30 positions. Screening of a pep-
tide library (Hensbergen et al., 2014) resulted in a broader selec-
tivity, accepting, for example, also less efficiently Ala in the P1 or
the P10 position (Figures 1C and 1D).
While there are numerous peptidases known to cleave Pro-X
and to a lesser extent X-Pro peptide bonds with X being any
amino acid beside Pro (Cunningham and O’Connor, 1997),
there are only few examples of Pro-Pro-bond cleavage. A survey
of the MEROPS database (Rawlings et al., 2014) resulted in
1,413 hits for Pro-X and 1,247 for X-Pro, but only 40 for Pro-
Pro peptide bond cleavage events; of the latter, 14 are attributed
to Zmp1.
To understand this striking sequence specificity and how
Zmp1 cleaves the proteolytically less sensitive peptide bond be-Structure 23, 1632–16tween two prolines, we have determined crystal structures of the
Zmp1 wild-type enzyme in the unbound state, as well as of
inactive mutants in complex with substrate- and product-like
peptides. These structures reveal a fold similar to anthrax LF cat-
alytic domain where a double-kinked conformation of the sub-
strate is enforced by a unique loop of Zmp1 as well as by an
active-site cleft that is shaped by an alternating aliphatic-aro-
matic side-chain stack. The shape and chemical nature of the
S sites nicely explain the substrate specificity of Zmp1. The
wild-type protein is crystallized in its fully active form, as demon-
strated by proteolytic activity assays based on fluorescence de-
quenching of synthetic peptides and on cleavage of two human
substrates.
This structural information can further be utilized for the devel-
opment of specific inhibitors that interfere with C. difficile
motility, which may support other therapeutic strategies.
RESULTS
Proteolytic Activity of Zmp1 Constructs
Fibronectin and fibrinogen were examined as proteinaceous
substrates in an activity assay at 37C with subsequent SDS-
PAGE analysis (Figures 2A and 2B). Fibronectin seems to be a
rather poor substrate for Zmp1, as even after 24 hr and a prote-
ase to substrate molar ratio of 5:1, no complete cleavage was
achieved (Figure 2A). Fibrinogen (b chain), on the other hand,
was almost completely digested by Zmp1 after 1 hr in a protease42, September 1, 2015 ª2015 Elsevier Ltd All rights reserved 1633
Figure 2. Proteolytic Activity of Zmp1 Variants
(A) Activity of Zmp1 against human fibronectin. Fibronectin (1 mM) was incu-
bated with Zmp1 (5 mM) for 1, 2, 3, and 24 hr and analyzed via SDS-PAGE. The
asterisks indicate cleavage products.
(B) Activity of Zmp1 against human fibrinogen. Fibrinogen (1 mM) was incu-
bated with Zmp1 (1 mMor 0.05 mM) for 1, 2, 3, and 24 hr and analyzed via SDS-
PAGE. The asterisk indicates the cleavage product (fibrinogen b chain).
(C) Activity of Zmp1 variants wild-type (wt), E143A, Y178F, and the double
mutant E143A/Y178F in a fluorescence dequenching-based assay using the
peptide Dabcyl-KEVNPPVPDE-Edans after 1 hr. The activity of the wild-type
enzyme was set to 100%. Error bars represent SD (n = 3).to substrate molar ratio of 1:1, and after 24 hr in a protease to
substrate molar ratio of 1:20 (Figure 2B).
To study the importance of the residues Glu143 and Tyr178,
which were assumed to be involved in the proteolytic mecha-
nism, different variants of Zmp1 were subjected to a de-
quenching-based fluorogenic activity assay. The internally
quenched fluorescence resonance energy transfer (FRET)-pep-
tide Dabcyl-KEVNPPVPDE-Edans (50 mM) was incubated with
1 mM of each Zmp1 variant: wild-type, the single mutants
E143A and Y178F, and the double mutant E143A/Y178F (Fig-1634 Structure 23, 1632–1642, September 1, 2015 ª2015 Elsevier Lture 2C). Compared to with wild-type Zmp1 (set to 100% cleav-
age after 1 hr at 37C), the single mutant Y178F displays 41%
activity and E143A 18% activity (Figure 2C). The double mutant
E143A/Y178F does not possess detectable proteolytic activity in
this assay. This high residual activity of both single mutants is
surprising. Usually, mutation of the glutamic acid of the HEXXH
motif leads to virtually complete inactivation, as shown for
numerous proteases of MEROPS clan MA, such as LF (Tonello
et al., 2004), astacin (Yiallouros et al., 2000), and aminopeptidase
A (Vazeux et al., 1996). Mutation of the transition state-stabilizing
tyrosine also completely abolishes proteolytic activity in the case
of LF and reduces it to a few percent in astacin.
Overall Structure of Zmp1
The data collection and refinement statistics for all reported
structures in this manuscript are given in Table 1. The overall
structure of Zmp1 (Figure 3) consists of an upper N-terminal
domain (NTD) and a lower helical C-terminal domain (CTD)
with respect to the active-site helix a4, which harbors two of
the three zinc-binding residues His142 and His146 and the
catalytic base Glu143 in the typical metalloprotease motif
(H142E143TAH146). Glu189 contributes to the second Zn2+ coordi-
nation sphere, with its side chain hydrogen bonding to the
imidazole ring of His142. Similarly for His146, there is a water-
mediated interaction with Asp149. The last five residues of helix
a4 (Ile148-Val152) are folded as a p helix (in i+5 conformation), a
feature occasionally found at the end of a helices. The NTD is
composed of a twisted four-stranded b sheet, three a helices
(a1–a3) backing the b sheet, and three short 310 helices (h1–
h3) connecting the strands b2 and b3. Furthermore, it accommo-
dates the edge strand b3, the bulge edge segment, and the
S-loop involved in substrate recognition and binding (nomencla-
ture similar to that used by Tallant et al., 2010). The CTD features
four a helices (a5–a8) and one 310 helix (h4). The third zinc ligand
Glu185 is located on helix a6, which connects the NTD and the
CTD. This feature ascribes Zmp1 to the clan of gluzincins
(Hooper, 1994). Opposite of the S-loop, the CTD harbors a
further determinant of substrate specificity, namely the S10-
wall-forming segment. It carries a tyrosine residue (Tyr178) that
probably acts as an electrophile by stabilizing the tetrahedral
transition state, analogous to astacins (Grams et al., 1996; Yial-
louros et al., 2000), serralysins (Hege and Baumann, 2001), and
thermolysin (Matthews, 1988). The phenolic OH group accepts a
hydrogen bond from the indole ring of Trp103, which is located at
the upper rim of the active-site cleft.
S-loop Flexibility
Twoalternative conformations of theS-loopwere observed in the
Zmp1 crystal structures reported here. In the unbound form
(Zmp1 wild-typeunbound and Zmp1 E143Aunbound), one of the
two molecules in the asymmetric unit shows an open conforma-
tion (Figure 4A), while the other and all four independent copies of
the peptide complex structures reveal a closed conformation
(Figure 4B). In the latter, the S-loop completely covers the primed
side of the substrate-binding groove (Figure 3). Substantial
movements of the backbone but also of several side chains are
necessary to perform this conformational change (Figure 4C),
with the largest being performed by Lys101 shifting the Ca
atom by 3 A˚ and the Nz atom by 10 A˚. Analysis with the DynDomd All rights reserved
Table 1. Data Collection and Refinement Statistics
Structure/Dataset Peak Zn-SAD Zmp1unbound Zmp1 E143Aunbound Zmp1 E143Aproduct Zmp1 E143A/Y178Fsubstrate
Data Collection
Space group P212121 P212121 P212121 P21 P21
a, b, c (A˚) 43.17, 71.68, 117.70 43.17, 71.77, 117.80 43.50, 72.39, 118.53 37.06, 42.96, 119.21 37.44, 42.94, 123.24b
a, b, g () 90, 90, 90 90, 90, 90 90, 90, 90 90, 92.54, 90 90, 96.1, 90
Wavelength (A˚) 1.28254 1.00 1.00 1.00 1.00
Resolutiona (A˚) 45.5–1.67 (1.72–1.67) 45.5–1.40 (1.49–1.40) 45.9–2.56 (2.71–2.56) 40.4–1.25 (1.33–1.25) 40.9–1.70 (1.80–1.70)
No. of observations 779,717 (34,025) 310,074 (45,851) 78,821 (10,167) 404,889 (56,107) 254,035 (31,806)
No. of unique reflections 80,960 (5,597) 71,874 (11,172) 12,587 (1,825) 102,218 (15,653) 43,083 (6,069)
Multiplicity 9.6 (6.1) 4.3 (4.1) 6.3 (5.6) 4.0 (3.6) 6.0 (5.2)
Completeness (%) 99.2 (93.0) 98.2 (95.6) 98.5 (91.8) 98.6 (93.7) 97.8 (87.8)
Rmerge
b (%) 6.8 (56.5) 5.2 (52.6) 17.7 (81.2) 4.4 (45.3) 12.3 (41.1)
Rmeas
b (%) 7.1 (61.7) 5.9 (60.2) 19.3 (89.3) 5.0 (52.6) 13.4 (45.2)
<I/s(I)> 21.86 (2.81) 15.66 (2.48) 9.74 (2.42) 15.82 (2.67) 9.58 (2.78)
CC1/2
c (%) 100 (85.1) 99.9 (85.5) 99.6 (86.2) 99.9 (85.1) 99.3 (86.3)
Refinement
Rwork/Rfree
d (%) 15.60/18.17 19.95/25.97 14.15/16.20 17.96/20.82
No. of non-H protein atoms 3,109 3,054 3,149 3,147
No. of water molecules 532 107 454 428
No. of ions/heavy atoms 2 Zn2+ 2 Zn2+ 2 Zn2+ 2 Zn2+
No. of other molecules – – 4 Glycerol –
No. of TLS groups/chain 9 3 8 8
Root-mean-square deviations
Bond lengths (A˚) 0.006 0.005 0.015 0.006
Bond angles () 1.022 0.629 1.489 0.932
Average B factor (A˚2)
All protein atoms 16.12 31.64 17.19 18.47
Water 29.74 27.69 30.44 31.11
Other atoms 10.12 30.32 11.06 67.76
Ramachandran plote (%)
Most favored 98.72 96.37 99.0 98.73
Additionally allowed 1.28 3.37 1.0 1.27
Disallowed 0 0.26 0 0
PDB entry 5A0P 5A0S 5A0R 5A0X
SAD, single-wavelength anomalous dispersion; CC, correlation coefficient.
aHighest-resolution shell in parentheses.
bRsym = SSjI(hkl; j) <I(hkl)>j/SS<I(hkl)> with I(hkl; j) being the jth measurement of the intensity of the unique reflection (hkl), and <I(hkl)> the mean over all symmetry-related measurements; Rmeas =
SS[n(hkl)/(n(hkl  1)]1/2jI(hkl; j)  <I(hkl)>j/SS<I(hkl)> (Diederichs and Karplus, 1997).
cCC1/2 from Diederichs and Karplus, 2013.
dRandom 5% of working set of reflections (Brunger, 1997).
eMolProbity (Chen et al., 2010).
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Figure 3. Structure of Zmp1
Overall structure of Zmp1 in cartoon representation. The N-terminal domain
(NTD) is colored slate blue, the active-site helix a4 orange, and the C-terminal
domain (CTD) green. The edge strand b3 (cyan), the diverting loop (light green),
the S-loop (yellow), the bulge edge segment (red), and the S10-wall-forming
segment (purple) are labeled. The residues involved in zinc ion binding, the
catalytic base, and the catalytic tyrosine are shown as sticks, and the zinc ion
as a sphere.server (Lee et al., 2003) yields a 98% closure of the S-loop with a
rotation angle of 19.4 around the bending residues Ser83-Leu86
and Pro114-Gly115. Those residues lie in the loops between
strand b2 and helixh1 and in the bulge edge segment right before
the edge strand b3, respectively. In the flexible part (Thr87-
Val113) three interactionsmediate S-loop closure in the unbound
crystal structure (Figure 4C, wheat). In the closed state, the
Lys101 side chain is involved in hydrogen bonds with the side
chains of Glu184 and Glu185 and a water molecule. In addition,
the phenolic OH group of Tyr182 OH interacts with Gly102 (dis-
tance of 2.83 A˚) and the side chain of Trp103 is engaged in a
hydrogen bond with Tyr178 OH (2.51 A˚). In the open conforma-
tion (yellow) all these interactions are broken, as the distance of
the involved residues from each other increases. In the peptide
complexes, closure is probably also triggered by the interaction
of Lys101 and the P2 Asn residue of the substrate (see below).
The S-loopExhibits a Function Analogous toB. anthracis
LF Domain III
LF from B. anthracis is a 90-kDa polypeptide composed of four
major domains (I–IV), of which domain IV is the catalytic metallo-1636 Structure 23, 1632–1642, September 1, 2015 ª2015 Elsevier Ltprotease domain (Figure 5). Together with domains II and III it
builds up a groove that recognizes and binds substrates (Panni-
fer et al., 2001; Maize et al., 2014). Domain III was recently shown
to be responsive to ligand binding and to change its conforma-
tion depending on the bound ligand/substrate (Pannifer et al.,
2001; Maize et al., 2014). We performed a structural alignment
of Zmp1 with B. anthracis LF (Figure 5). The major part of
Zmp1 aligns to LF domain IV with a root-mean-square deviation
of 2.48 A˚ over 157 aligned residues. Interestingly, the S-loop
spatially superposes with a part of LF domain III. Analogous to
the interaction of LF domains III and IV (Pannifer et al., 2001),
the S-loop shares a hydrophobic interface with the part of the
NTD covered by the S-loop. From these findings and the afore-
mentioned large movements, we conclude that the S-loop
exhibits a function similar to that of LF domain III, and thus con-
tributes to sequence specificity and substrate binding.
Substrate Recognition
In a first attempt to structurally characterize substrate binding to
Zmp1, co-crystallization trials were set up using the substrate
octapeptide Ac-EVNPPVPD-NH2 and the Zmp1 mutant Zmp1-
E143A, where the catalytic base of the HEXXH motif is mutated
to Ala. After a few days a new crystal form in space group P21
appeared. Surprisingly, only the unprimed part Ac-EVNP-
COOH of the peptide was discernible in the electron density
with a very clear defined carboxy terminus. A glycerol molecule
was found in the primed part of the active-site cleft (Figure 6A).
Thus, despite the mutation of the catalytic base Glu143, some
residual proteolytic activity is retained, as also demonstrated in
activity tests using an internally quenched fluorogenic substrate
peptide (see above).
To obtain crystals of Zmp1 with the full-length substrate
peptide, comprising primed and unprimed sites, two changes
were introduced based on the observations of the product
peptide complex. The peptide was shortened at the C ter-
minus by one residue, resulting in the heptapeptide Ac-
EVNPPVP-NH2, to make it fit into the crystal packing of the
monoclinic space group. To abolish residual activity, the double
mutant E143A/Y178F was prepared, which indeed proved to be
proteolytically inactive. The two complex structures are identical
with respect to the interactions made by the unprimed peptide
residues.
In the substrate peptide, all X-Pro peptide bonds are in the
trans conformation, while potential cis conformers are probably
unable to bind in a productive manner. The peptide binds in an
antiparallel fashion to the edge strand of the protease, but the
approximate angle between the peptide backbone and the pro-
tease b-sheet plane is about 30, so only two main-chain
hydrogen bonds are formed via the P4 and P1 main-chain
carbonyl oxygen atoms. The Pro at the P10 position introduces
a sharp bend, turning the course of the backbone away from
the edge strand. This is very different from LF-peptide com-
plexes (PDB: 1PWV; Turk et al., 2004) where the P10 tyrosine
has backbone dihedral angles (F, J) of (169, 66), while in
Zmp1 these angles are (75, 177) and the restricted conforma-
tion of the proline F angle does not allow a more b-strand-like
conformation.
Interestingly, the primed site of the peptide is bound in a ‘‘dou-
ble-kinked’’ conformation, with an angle of 122 (along thed All rights reserved
Figure 4. Conformational Space of the S-loop
(A) Surface representation of the open conformation of the S-loop. Important residues are shown as sticks in both (A) and (B).
(B) Surface representation of the closed conformation of the S-loop.
(C) Movement of important residues in S-loop opening and closure (indicated by double-sided arrows). K101 performs the largest movement from the closed
conformation (wheat) to the open conformation (yellow), followed by E104 and other residues in the S-loop. Three residues mediate the closure: K101 interacts
with E184 and E185, G102 with Y182, and W103 with Y178 (indicated by dashed lines).neighboring Ca atoms Asn3*-Pro4* and Pro4*-Pro5*), when
considering the P10 residue Pro5* (Ca) as the hinge and 109 at
the P20 residue Val6* (Ca) as the second hinge (Figure 6B). The
first kink is necessary to overcome the steric hindrance pro-
duced by the long loop composed of residues Ser128–Asp135,
which diverts a 180 exit from the substrate-binding site and
forces the peptide to adopt this specific conformation. We
named this loop the ‘‘diverting loop’’ (Figures 3, 5, and 7). This
loop connects the b4 strand and the active-site helix. In anthrax
LF this loop is shortened by four residues and the active-site
helix is elongated by three residues at its N terminus (Figure 7).
Therefore the loop is more flat and 6 A˚ further away from the cat-
alytic zinc ion than in Zmp1, thus allowing a straighter course of
the substrate backbone (Figure 7).
There are various interactions of the side chains of the sub-
strate, explaining nicely the observed substrate specificity (Fig-
ure 1B). The ammonium group of Lys101 interacts with the P2
residue Asn3* (Od1) accompanied by a complete closure of the
S-loop. The NH2 group of the Asn3* side chain forms a hydrogen
bondwith themain-chain carbonyl oxygen atom of Gly117 that is
located on the edge strand. These two interactions explain the
observed preference for Asn at the P2 position.
In addition to hydrogen bonds, the peptide is bound by hy-
drophobic/van der Waals interactions (Figures 6 and S1), which
are also determinants of substrate specificity. The top of the
unprimed part of the substrate-binding cleft up to the P10 posi-
tion is built by an unusual network of alternating aliphatic and
aromatic residues that are aligned in a beads-on-a-string like
fashion, starting from Tyr94 located on helix h2 through
Leu95, Trp110, Pro100, and ending at Trp103, all located on
the S-loop and the bulge edge segment. The latter three
amino acids stack against each other in an almost parallel
orientation of their side chains. Pro100 and Val113 together
with Trp110 and Trp103 encircle the peptide P1 proline residue
and form a hydrophobic pocket that snugly accommodates the
five-membered ring. The importance of the hydrophobic resi-Structure 23, 1632–16dues in the S-loop and the bulge edge segment is further
substantiated by the fact that they are conserved throughout
the species (Figure S2). Leu95, Pro100, Trp110, Val113, and
Pro114 are strictly conserved, and the amino acid at position
103 is an aromatic residue, either a tryptophan or a tyrosine
residue.
In the product peptide complex structure with Zmp1-E143A,
the C terminus of the proline P1 residue (Pro4*) coordinates
the catalytic zinc ion via one oxygen atom of its carboxylate
group, completing the tetrahedral zinc coordination together
with His142 (Nε2), His146 (Nε2), and Glu185 (Oε1).
The proline at P10 position (Pro5*) is perfectly embedded in the
S10 subsite (Figure 6B). Its side chain interacts with His142,
His134, Ala136, and Leu139. Its main-chain carbonyl oxygen ac-
cepts a hydrogen bond from the Trp103 side chain. The back-
bone carbonyl oxygen of the P20 residue (Val6*) makes a
hydrogen bond to the backbone NH group of Asp135. The S20
subsite is composed of the side chains of Asp135, Ala136,
Asn175, Tyr178, and Leu179 (Figure 6B). Asp135 is located at
the bottom of the S20 subsite and restricts the size of the pocket.
The proline at P30 completes the unique aliphatic-aromatic
network (Tyr94–Trp103) described above, by aligning as the
last residue at the rim of the network (Figure 6B). This produces
the second kink in the substrate between the axes Pro5*-Val6*
and Val6*-Pro7* with an angle of about 109. The pyrrolidine
ring of proline is in perfect parallel orientation to the indole ring
of Trp103 and in a 90 angle to the benzene ring of Phe178 (in
wild-type Zmp1 to the phenol ring of Tyr178). It interacts with
the side chain of Trp103, Thr106, Phe178 (Tyr178), and a water
molecule that is bound to the side chain of Asn175. The back-
bone oxygen is bound to two water molecules coordinated by
Asn175. The amide that remains attached at the C terminus of
the peptide after cleavage from the Rink amide resin during
solid-phase synthesis points toward the solvent and indicates
the direction in which the C-terminal residues (P40 and further
residues) would be located.42, September 1, 2015 ª2015 Elsevier Ltd All rights reserved 1637
Figure 5. Zmp1 Is Structurally Similar to
Anthrax Lethal Factor Metalloprotease
Domain IV
Superposition of Zmp1 with B. anthracis LF in
stereo view. Zmp1 (red) superposes well with LF
metalloprotease domain IV (cyan), and the Zmp1
S-loop aligns partially with LF substrate-binding
domain III (orange).DISCUSSION
On the basis of the crystal structures reported here, we are now
able to link the knowledge about sequence specificity described
earlier (Cafardi et al., 2013; Hensbergen et al., 2014) to structural
features of Zmp1. The residue at position P4 forms two back-
bone interactions to Ser119 (Figures 6A and S1). The side chain
of the glutamate at P4 interacts directly with N3* of the peptide
itself and with His150 (Figures 6A and S1), but also makes
water-mediated interactions with Asp149 and Asp155 side-
chain carboxyl groups. Owing to the many different possible in-
teractions, the S4 pocket seems to be suitable for many different
side chains, thus high sequence variability can be expected at
position P4. The S3 pocket is built up and restricted in size by
the three hydrophobic residues Tyr94, Leu95, and Trp110; it is
backed up by Leu116 located on the edge strand b3 (Figures 6
and S1). With this configuration a preference for non-polar
aliphatic residues at P3 can be explained (Figure 1B). The
C. difficile substrates CD2831 and CD3246, which possess mul-
tiple cleavage sites, show only asparagine at position P2 (Fig-
ure 1B). In the substrate complex crystal structure, this side
chain is stabilized by five interactions (Figures 6A and S1).
Because of its size and charge distribution, asparagine is the
only amino acid that can form all five interactions. The interaction
with Lys101 is the one that drives S-loop closure and probably
locks the peptide into the right conformation to position the
P1/P10 prolines for efficient cleavage. The amino acids Pro100,
Trp103, Trp110, Val113, His134, and Leu139 (Figure 6) deter-
mine the size and hydrophobicity of the S1/S10 pocket. This
explains why only proline and alanine residues are tolerated at
the substrate positions P1 and P10. Alanine can adopt many
more main-chain conformations than proline, which makes
such a peptide more flexible and causes a higher entropy loss
at the substrate-binding pocket. This explains why alanine-
containing peptides at the P1 or P10 positions are less efficiently
cleaved (Hensbergen et al., 2014). In addition, alanine makes
fewer interactions with the surrounding aromatic and aliphatic
residues. At position P20 aliphatic residues such as valine, isoleu-
cine, and alanine are found.While valine fits very well, the alanine
side chain does not fill the S20 pocket, and larger amino acids
such as leucine or the aromatic residues would produce steric1638 Structure 23, 1632–1642, September 1, 2015 ª2015 Elsevier Ltd All rights reservedclashes with Glu189 at the bottom of
the S20 site and with Asn175 and
Leu179 flanking it to the solvent. Proline
at P30 is strictly conserved in the endoge-
nous substrates (Figure 1B). Its side chain
stacks against the indole ring of Trp103 of
the aliphatic-aromatic stacking network
(Figure 6B).Proline is unique among the proteinogenic amino acids owing
to its secondary amino group functionality whereby the aliphatic
side chain is bonded to the nitrogen. This restricts its conforma-
tional flexibility to a backbone F angle of about 75. Further-
more, its a-amino group in a peptide bond lacks the polar amide
hydrogen and cannot act as H-bond donor, and the X-Pro pep-
tide link is more prone than other peptide bonds for the
cis conformation. The imino-peptide bond synthesis is more
difficult than for other amino acids: Ribosomes show a much
slower incorporation rate (Pavlov et al., 2009), and in bacteria
the special elongation factor eF-P is needed to prevent ribosome
stalling at proline-rich sequences (Doerfel et al., 2013; Ude et al.,
2013).
Likewise, enzyme-catalyzed hydrolysis of proline-containing
peptide bonds also appears to be difficult, and a rather limited
set of proteases is known to be able to cleave proline-adjacent
peptide bonds. Because most proteolytic enzymes bind their
substrates as an additional b strand in an extended conformation
at the edge of a b sheet (Madala et al., 2010; Gomis-Ruth et al.,
2012), proline-containing substrates are obviously much less
suited for this binding mode since it requires a F angle of
about 139. In addition, owing to the higher basicity of the
a-amino group (or imino group) of proline, it is a worse leaving
group than other residues.
As mentioned earlier, only 40 genuine cleavage events of Pro-
Pro peptide bonds are documented in the MEROPS database,
thus corroborating the particular resilience of this bond to
enzyme-catalyzed hydrolysis (Vanhoof et al., 1995).
C. difficile Zmp1 is the first protease that has a described
specificity for such Pro-Pro peptide bonds. The substrate-bind-
ing cleft of Zmp1 is shaped to handle non-extended, kinked pep-
tide conformations, partly owing to the unique diverting loop that
is absent in LF (Figure 7) and other metalloproteases such as
thermolysin. Another striking feature of Zmp1 that might be
related to its ability to cope with Pro-Pro peptide bonds is the
surprisingly high residual proteolytic activity found in the
active-site single mutants E143A and Y178F (Figure 2C). While
analogous mutations in LF (Tonello et al., 2004) and astacin
(Yiallouros et al., 2000) almost completely inactivate the respec-
tive enzymes, Zmp1 seems to overcome this handicap to a
certain extent, at least in an in vitro situation with a peptidic
Figure 6. Product and Substrate Complex
of Zmp1
(A) Unprimed substrate-binding site of Zmp1
occupied by the N-terminal product (Ac-EVNP-
OH) after cleavage of the substrate peptide. The
protein is in cartoon representation (cyan); the
substrate-binding subsites S4–S1 are marked by
half-circles. The peptide (green) and the edge
strand b3 are shown as sticks, and dashed lines
indicate the most important interactions.
(B) Substrate peptide Ac-EVNPPVP-NH2 (orange)
bound to the Zmp1 substrate-binding site. Dashed
lines indicate the most important interactions be-
tween the peptide and the primed substrate-
binding site of Zmp1. A dashed ruler highlights the
kink in the peptide with a 122 angle at Pro5* and a
109 angle at Val6*. See also Figures S1 and S2.substrate under the conditions described. It appears that the
zinc-coordinating water molecule is reactive enough even
without an assisting catalytic base (glutamic acid). Furthermore,
the addition of water to the carbonyl carbon of the scissile pep-
tide bond may not be the rate-determining step, as has been
shown for the HIV-protease-assisted Phe-Pro peptide bond
hydrolysis, where proton transfer to the P10 nitrogen is the
slowest step (Okimoto et al., 1999). Some residual activity of
the analogous E/A mutant enabling activation of profragilysin
has been described, but without further quantification (Goulas
et al., 2011).
Eventually, the surprising Pro-Pro specificity may also have its
origin in the unique aromatic-aliphatic side-chain stack at the
upper rim of the active-site cleft, together with the diverting
loop and the mobile S-loop. These elements uniquely shape
the active-site cleft.
EXPERIMENTAL PROCEDURES
Cloning of Wild-Type Zmp1
The truncated (amino acids 27–220, lacking the native signal peptide) version
of the gene zmp1 (CD2830) from C. difficile strain 630, codon-optimized for
Escherichia coli (Geneart, Thermo Fisher Scientific), was PCR amplified
using the oligonucleotides Zmp1-fw: 50-GGAATTCCATATGGATAGCACCAC
CATTC-30 and Zmp1-bw: 50-CCGCTCGAGTTATTTTGCCAGATTCTG-30, and
was subcloned into vector pET28a (Merck-Millipore) using the restriction sites
NdeI and XhoI. This construct yields a protein with a thrombin-cleavable N-ter-
minal 6x-His tag.
Mutagenesis of Zmp1
Active-site mutants were generated using the protocol published earlier
(Zheng et al., 2004). For the E143A mutant the PCR was performed using
pET28a-Zmp1 as template and the oligonucleotides Zmp1-E143A-fw:
50-GAACTGCATGCAACCGCACATGCCATTG-30 and Zmp1-E143A-bw:
50-GCGGTTGCATGCAGTTCCAGATTAATG-30. For the constructs pET28a-
Zmp1(Y178F) and pET28a-Zmp1(E143A/Y178F), the vectors pET28a-Zmp1
wild-type and pET28a-Zmp1(E143A), respectively, were used as templates
and the following oligonucleotides: Zmp1-Y178F-fw: 50-GTTAATTTTCT
GGGTGTTTATCCG-30 and Zmp1-Y178F-bw: 50-CCCAGAAAATTAACATT
GCCCAGG-30. A reaction with 18 cycles was performed with an annealing
temperature of 60C for 1 min and an elongation step at 68C for 18 min.
The reactions (50 ml) were purified using a PCR cleanup kit (Sigma-Aldrich)
and digested with 1 U DpnI for 1 hr at 37C. 4 ml of the reactions was trans-
formed into competent E. coli TOP10 cells (Invitrogen), plated on LB agar
plus 50 mg/ml kanamycin plates, and incubated overnight at 37C. The pre-
pared vectors were sequenced to identify positive clones.Structure 23, 1632–16Expression of Zmp1 Constructs
The resulting vectors pET28a-Zmp1 wild-type, pET28a-Zmp1(E143A),
pET28a-Zmp1(Y178F), and pET28a-Zmp1(E143A/Y178F) were transformed
into competent BL21 Star (DE3) cells (Invitrogen) by heat shock, plated on
LB agar plus 50 mg/ml kanamycin plates, and incubated overnight at 37C.
Precultures grown overnight from a single colony at 37C were used to inocu-
late 1 l of expression culture (LB medium plus 50 mg/ml kanamycin) to an
optical density at 600 nm (OD600) of 0.1. Gene expression was induced with
0.5 mM isopropyl-b-D-1-thiogalactopyranoside at an OD600 of 0.6, and cell
growth was continued for another 4 hr at 37C. Cells were harvested by centri-
fugation at 7,000 3 g, 4C for 20 min. Cell pellets were washed with Tris-
buffered saline (TBS) (20 mM Tris [pH 7.5], 200 mM NaCl), pelleted again,
and stored at 80C until use.
Purification of Zmp1 Constructs
A cell pellet from 1 l of culture was solubilized in TBS with 10 mg/ml DNaseI
(AppliChem). Cells were lysed on ice/water by sonication for 15 min at
30% amplitude (Vibra-Cell VCX500, Sonics), cell debris was pelleted at
10,0003 g, for 10 min at 4C, and the supernatant was cleared by ultracentri-
fugation at 165,000 3 g at 4C for 30 min. The supernatant was adjusted with
1 M imidazole (pH 7.5) to a final concentration of 10 mM imidazole and loaded
onto 2-ml NiNTA Superflow resin (Qiagen). Protein was eluted (TBS, 250 mM
imidazole) after two wash steps with 10 mM and 30 mM imidazole. Protein
concentration was determined at 280 nm using themolar extinction coefficient
of 25,900 M1 cm1, and 2 U of thrombin (Sigma-Aldrich) per milligram of pro-
tein were added, followed by dialysis overnight at 4C against a 50-fold volume
of TBS. The protein was applied onto the sameNiNTA Superflow column equil-
ibrated with TBS supplemented with 10 mM imidazole, and the flow-through
was collected. The protein was concentrated and applied onto a HiLoad
Superdex 200 16/600 column (GE Healthcare) equilibrated with TBS. Zmp1
constructs eluted as single peaks corresponding to a size of 20 kDa. The yield
for all constructs was 50 mg of protein per liter of culture.
Crystallization
All crystals were grown by the sitting-drop vapor diffusion technique. For the
orthorhombic unbound form, wild-type protein (12 mg/ml) was mixed with pre-
cipitant in a ratio of 2:1 to form 3-ml drops that were then equilibrated at 20C
against 1.8–2.55 M ammonium phosphate and 0.1 M Tris (pH 7.5–9.0). Highly
intergrown crystals appeared after 2 days. Seeds were prepared (Beads-for-
Seeds, Jena Biosciences) and diluted 1:1,000 in the original reservoir solution.
1 ml of seeds was added to the wells containing 1.8–2.25 M ammonium phos-
phate (pH 7.5–9.0) to yield well-ordered crystals in all conditions after another
2 days. Data were collected from a crystal grown in 2.1 M ammonium phos-
phate, 0.1 M Tris (pH 8.0) that was cryoprotected with 20% glycerol.
Orthorhombic crystals of the Zmp1 E143A variant were grown by mixing
protein (11 mg/ml) in a 1:2 ratio with precipitant (2.1 M D/L-malic acid [pH
7.0]) to form 300-nl drops at 20C. Needle clusters appeared after 2 weeks.
Single crystals were released using two acupuncture needles as tools, and
flash-frozen in liquid nitrogen without further cryoprotection.42, September 1, 2015 ª2015 Elsevier Ltd All rights reserved 1639
Figure 7. The Diverting Loop Is a Unique Feature of Zmp1
Close-up stereo view of Zmp1 (orange) and anthrax LF (yellow) along the
substrate-binding groove. The substrate-heptapeptide in Zmp1 and the sub-
strate-undecapeptide in LF are shown as sticks. The diverting loop (green), the
S-loop (slate blue), and the zinc ion are indicated.For the product-complex of Zmp1(E143A) with the substrate peptide Ac-
EVNPPVPD-NH2, the protein (11 mg/ml) was mixed with a 7-fold molar excess
of the peptide in TBS and incubated at 20C for 30 min before plate set-up.
Crystals appeared in various conditions after a few days. The best diffracting
crystals were obtained after seeding from a condition containing 1.8 M ammo-
nium phosphate dibasic, 0.1 M Tris (pH 8.5), with a protein to precipitant ratio
of 2:1 in 3-ml drops. Data were collected from crystals that were cryoprotected
with 20% glycerol. For the substrate peptide complex of Zmp1(E143AY178F),
protein (12 mg/ml) was mixed with a 10-fold molar excess of the peptide Ac-
EVNPPVP-NH2 in TBS and incubated at 20
C for 30 min. Conditions with clear
drops were seeded with seeds diluted 1:250 in the original reservoir solution
2.1 M ammonium phosphate dibasic, 0.1 M Tris (pH 8.0) (prepared as
described above), and best diffracting crystals were obtained from 2.25
ammonium phosphate dibasic, 0.1 M Tris (pH 9.0) as precipitant with a protein
to precipitant ratio of 2:1 in 3-ml drops. Data were collected from crystals cry-
oprotected with 30% sucrose-supplemented precipitant solution.
Data Collection and Structure Determination
Crystals were screened in-house using a rotating anode MicroMax-007 HF
(Rigaku, Japan) equipped with a Mar345 image plate (MAR Research,
Germany). High-resolution data were collected at the Swiss Light Source,
Paul-Scherrer-Institute, Villigen, Switzerland, on beamlines X06DA or X06SA
using Pilatus 2M and Pilatus 6M detectors (Dectris). All diffraction data were
processed using XDS (Kabsch, 2010). For wild-type Zmp1unbound (crystal
form I), a peak dataset at a wavelength of 1.283 A˚ was collected in the in-
verse-beammode. The structure was solved by single-wavelength anomalous
dispersion using phases computed from the two zinc sites by the
phenix.autosol routine of the PHENIX package (Adams et al., 2010) and an
almost complete model was automatically built. The model was refined using
iterative cycles of phenix.refine (Afonine et al., 2012) and manual model build-
ing in Coot (Emsley et al., 2010). For the orthorhombic crystal form Zmp1
E143Aunbound and the monoclinic crystal forms Zmp1 E143Aproduct and
Zmp1 E143A/Y178Fsubstrate, native datasets were collected at a wavelength
of 1.0 A˚. The structure was solved by molecular replacement with one mono-
mer from crystal form I as search model by the program Phaser (McCoy et al.,
2007), and refined as described above. All data collection and refinement sta-
tistics are given in Table 1.
Activity Assay Using an Internally Quenched Fluorogenic Peptide
The reaction of the fluorogenic substrate peptide containing an N-terminal
Lys-Dabcyl group and a C-terminal Glu-EDANS group was measured by the
increase in fluorescence at 485 nm that occurs upon cleavage of any peptide
bond in the peptide sequence (Dabcyl)KEVNPPVPDE(EDANS). The substrate
(50 mM)was incubated for up to 60min at 37Cwith 1 mMZmp1wild-type or its
variants, respectively, in a 96-well plate (black pureGrade S, Brand) using the1640 Structure 23, 1632–1642, September 1, 2015 ª2015 Elsevier LtSynergy H4 plate reader (Biotek) in PBS (12 mM Na2HPO, 1.2 mM KH2PO,
137 mM NaCl, 2.7 mM KCl [pH 7.5]).
Activity Assay Using Fibrinogen and Fibronectin
Long-term reactions of 5 mM Zmp1 with 1 mM fibronectin from human plasma
(Sigma-Aldrich) and reactions of 0.05 and 1 mM Zmp1 with 1 mM fibrinogen
type I from human plasma (Sigma-Aldrich) were set up at 37C in PBS. The
sample volume was set to 100 ml and samples of 20 ml were taken after 1, 2,
3, and 24 hr before analysis on 10% SDS-PAGE gels.
Solid-Phase Peptide Synthesis
The substrate peptides Ac-EVNPPVPD-CONH2 and Ac-EVNPPVP-CONH2
were synthesized by automated multiple solid-phase peptide synthesis (SyroI;
MultiSynTech) on the 4-(20,40-dimethoxyphenyl-Fmoc-aminomethyl)-phenoxy
(Rink amide) resin (Novabiochem; 30 mg, resin loading 0.5 mmol/g) using the
fluorenylmethoxycarbonyl/tert-butyl-strategy utilizing a double coupling pro-
cedure and in situ activation with Oxyma Pure-N,N0-diisopropyl-carbodiimide
(Oxyma-DIC) (Novabiochem and IRIS Biotech). N-Terminal acetylation was
carried out using 10 equivalents (eq.) of acetic anhydride (Ac2O; Sigma-
Aldrich) activated with 10 eq. of N,N–diisopropylethylamine (DIPEA; Fluka) in
dichloromethane (Biosolve) under vigorous shaking for 2 hr. Peptides were
cleaved from the resin with trifluoroacetic acid (TFA), triisopropylsilane (TIS;
both from Fluka), and water (95:2.5:2.5, v/v/v) at room temperature. Products
were precipitated with ice-cold n-hexane (Merck)/diethyl ether (Biosolve)
(1:3, v/v), collected by centrifugation, washed four times, and lyophilized
from water with tert-butyl alcohol (Fluka) (3:1, v/v). Purification was carried
out by preparative reverse-phase high-performance liquid chromatography
(HPLC) on a 90-A˚ C18 Jupiter column (Phenomex), and analyzed using a
liquid chromatography-electrospray ionization-mass spectrometry instrument
(LCQ, Finnigan MAT, Thermo Scientific). The final purity of the HPLC-purified
and lyophilized peptide was >95%.
For the synthesis of the internally quenched fluorogenic peptide Ac-
K(Dabcyl)EVNPPVPDE(EDANS)-CONH2, Fmoc-L-glutamic acid-g-[2-(1-sulfo-
nyl-5-naphthyl)-aminoethylamide (Fmoc-Glu(EDANS)-OH) (3 eq.) was coupled
three times with 3 eq. of O-(7-azabenzotriazol-1-yl)-1,1,3,3-tetramethyluro-
nium hexafluorophosphate-DIPEA (HATU-DIPEA; Fluka) on Rink amide resin
(30 mg, resin loading 0.5 mmol/g) for 3 hr. Afterward the remaining amine
groups on the resin were blocked by acetylation using 10 eq. of Ac2O and
10 eq. of DIPEA for 15 min. Subsequently the peptide was N-terminally
extended by automated multiple solid-phase peptide synthesis as described
for the substrate peptide. Fmoc-ε-(4,4-dimethylazobenzene-40-carbonyl)-L-
lysine (Fmoc-L-Lys(Dabcyl)-OH) (3 eq.) was manually coupled using either
3 eq. of HATU-DIPEA or 3 eq. of Oxyma-DIC until Kaiser tests were negative
(Kaiser et al., 1970). The FRET peptide was further treated as described above.
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